Funding for this research was provided by:
Bristol-Myers Squibb (BMSF STF Application 470)
Received: 20 October 2017
Accepted: 17 December 2018
First Online: 24 January 2019
: Lovemore Makurirofa holds a Diploma in occupational health and safety from the University of Zimbabwe, College of Health Sciences, a Bachelor of Arts from the University of Zimbabwe and MSc in Population Studies from the University of Zimbabwe, Centre for Population Studies. He is currently the Information, Research and Evaluation Manager for the Cancer Association of Zimbabwe. He designed the Mudzi cancer education and screening project and was responsible for the administration, monitoring, evaluation and reporting of the Mudzi cancer education and screening project. He is also one of the current advisory techinical committee members of the Zimbabwe National Cancer Registry. He has passion for research.
: Medical Research Council of Zimbabwe (MRCZ) approval. The study was also approved by the Cancer Association of Zimbabwe board and the local rural authorities including District Administrator (DA) and District Medical Officer (DMO). The study respected freedom to participate and adhered to research principles pertaining to privacy and confidentiality and consent was sought from all the participants including parental consent and assent for the participants below 18 years. Written consent was sought from the participants except 17 participants from which we failed to get written consent. We submitted a protocol deviation for the failure to get written consent and relied on verbal consent from the 17 participants out of the total of 409 participants enrolled in the survey. The protocol deviation was sought by the authors and was approved by the Medical Research Council of Zimbabwe on 28 August 2014.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.